|
FDA Works With Generic Makers in U.S., Abroad After Ameridose Recall
The FDA is working with manufacturers to ramp up production of six generic drugs after an Ameridose recall last week.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives